These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28952056)

  • 1. Pathophysiology of acute heart failure syndrome: a knowledge gap.
    Sabbah HN
    Heart Fail Rev; 2017 Nov; 22(6):621-639. PubMed ID: 28952056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and clinical evaluation of acute heart failure.
    Mentz RJ; O'Connor CM
    Nat Rev Cardiol; 2016 Jan; 13(1):28-35. PubMed ID: 26370473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure.
    Chan WW; Waltman Johnson K; Friedman HS; Navaratnam P
    Hosp Pract (1995); 2016 Aug; 44(3):138-45. PubMed ID: 27292609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying cardiac hemodynamic stress and cardiomyocyte damage in ischemic and nonischemic acute heart failure.
    Drexler B; Heinisch C; Balmelli C; Lassus J; Siirilä-Waris K; Arenja N; Socrates T; Noveanu M; Potocki M; Meune C; Haaf P; Degen C; Breidthardt T; Reichlin T; Nieminen MS; Veli-Pekka H; Osswald S; Mueller C
    Circ Heart Fail; 2012 Jan; 5(1):17-24. PubMed ID: 21976469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
    Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR;
    J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome.
    Torre-Amione G; Milo-Cotter O; Kaluski E; Perchenet L; Kobrin I; Frey A; Rund MM; Weatherley BD; Cotter G
    J Card Fail; 2009 Oct; 15(8):639-44. PubMed ID: 19786251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF).
    Nagai T; Honda Y; Nakano H; Honda S; Iwakami N; Mizuno A; Komiyama N; Yamane T; Furukawa Y; Miyagi T; Nishihara S; Tanaka N; Adachi T; Hamasaki T; Asaumi Y; Tahara Y; Aiba T; Sugano Y; Kanzaki H; Noguchi T; Kusano K; Yasuda S; Ogawa H; Anzai T
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):551-557. PubMed ID: 29098501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of decreased peripheral congestion detected by Bioelectrical Impedance Vector Analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure.
    Santarelli S; Russo V; Lalle I; De Berardinis B; Vetrone F; Magrini L; Di Stasio E; Piccoli A; Codognotto M; Mion MM; Castello LM; Avanzi GC; Di Somma S;
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):339-347. PubMed ID: 27073131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of Heart Failure Is an Important Predictor of Outcomes After Mechanical Circulatory Support.
    Loyaga-Rendon RY; Acharya D; Pamboukian SV; Tallaj JA; Cantor R; Starling RC; Naftel DC; Kirklin JK
    Circ Heart Fail; 2015 Sep; 8(5):953-9. PubMed ID: 26251182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of acute heart failure.
    Milo-Cotter O; Bettari L; Kleijn L; Bugatti S; Lombardi C; Rund M; Metra M; Voors AA; Cotter G; Kaluski E; Weatherley BD
    Panminerva Med; 2010 Mar; 52(1):53-66. PubMed ID: 20228726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute heart failure : An unmet medical need.
    Rigopoulos AG; Bakogiannis C; de Vecchis R; Sakellaropoulos S; Ali M; Teren M; Matiakis M; Tschoepe C; Noutsias M
    Herz; 2019 Feb; 44(1):53-55. PubMed ID: 28939928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute heart failure: More questions than answers.
    Tomasoni D; Lombardi CM; Sbolli M; Cotter G; Metra M
    Prog Cardiovasc Dis; 2020; 63(5):599-606. PubMed ID: 32283133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute heart failure: lessons learned so far.
    Howlett JG
    Can J Cardiol; 2011; 27(3):284-95. PubMed ID: 21601768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.
    Pang PS; Teerlink JR; Boer-Martins L; Gimpelewicz C; Davison BA; Wang Y; Voors AA; Severin T; Ponikowski P; Hua TA; Greenberg BH; Filippatos G; Felker GM; Cotter G; Metra M
    Am Heart J; 2017 May; 187():62-69. PubMed ID: 28454809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score.
    Raslan IR; Brown P; Westerhout CM; Ezekowitz JA; Hernandez AF; Starling RC; O'Connor C; McAlister FA; Rowe BH; Armstrong PW; van Diepen S
    Am Heart J; 2017 Jun; 188():127-135. PubMed ID: 28577668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF.
    Grodin JL; Lala A; Stevens SR; DeVore AD; Cooper LB; AbouEzzeddine OF; Mentz RJ; Groarke JD; Joyce E; Rosenthal JL; Vader JM; Tang WH
    J Card Fail; 2016 Nov; 22(11):884-890. PubMed ID: 26844764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry.
    Tavazzi L; Senni M; Metra M; Gorini M; Cacciatore G; Chinaglia A; Di Lenarda A; Mortara A; Oliva F; Maggioni AP;
    Circ Heart Fail; 2013 May; 6(3):473-81. PubMed ID: 23476054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
    Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
    J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiology of acute heart failure--is it all about fluid accumulation?
    Cotter G; Felker GM; Adams KF; Milo-Cotter O; O'Connor CM
    Am Heart J; 2008 Jan; 155(1):9-18. PubMed ID: 18082483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.